Compare NATR & IGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NATR | IGD |
|---|---|---|
| Founded | 1972 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 470.3M | 463.0M |
| IPO Year | 1995 | N/A |
| Metric | NATR | IGD |
|---|---|---|
| Price | $25.87 | $5.86 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $21.33 | N/A |
| AVG Volume (30 Days) | 108.1K | ★ 284.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.15% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.83 | N/A |
| Revenue | ★ $454,364,000.00 | N/A |
| Revenue This Year | $7.30 | N/A |
| Revenue Next Year | $3.44 | N/A |
| P/E Ratio | $32.86 | ★ N/A |
| Revenue Growth | ★ 2.03 | N/A |
| 52 Week Low | $11.01 | $5.01 |
| 52 Week High | $28.14 | $6.04 |
| Indicator | NATR | IGD |
|---|---|---|
| Relative Strength Index (RSI) | 47.22 | 46.56 |
| Support Level | $13.69 | $5.84 |
| Resistance Level | $26.96 | $5.98 |
| Average True Range (ATR) | 0.92 | 0.05 |
| MACD | -0.21 | -0.01 |
| Stochastic Oscillator | 13.83 | 20.45 |
Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.
Voya Global Equity Dividend and Premium Opportunity Fund are a United States-based diversified, closed-end Fund. The primary objective of the Fund is to seek to provide investors with a high level of income from a portfolio of common stocks with historically attractive dividend yields and premiums from call option writing. The secondary investment objective of the company is capital appreciation. Under normal market conditions, the Fund will invest at least 80% of its managed assets in a portfolio of common stocks of dividend-paying companies located throughout the world.